1. Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study
   Liang Yin et al, 2023, Cancer Imaging CrossRef
2. Pigment epithelium-derived factor and its role in microvascular-related diseases
   Yuzhuo Wang et al, 2022, Biochimie CrossRef
3. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
   Song Gao et al, 2022, Frontiers in Pharmacology CrossRef
4. Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer
   Sho-ichi Yamagishi et al, 2019, Current Pharmaceutical Design CrossRef
5. Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis
   Yan Wei et al, 2019, Chemotherapy CrossRef
6. Prognostic Evaluation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Patients Treated with Transarterial Chemoembolization Plus Molecular Targeted Therapies—Development and Validation of the ABPS Score
   Kaicai Liu et al, 2024, Academic Radiology CrossRef
7. Cordyceps militaris fraction inhibits angiogenesis of hepatocellular carcinoma in vitro and in vivo
   Liyan Song et al, 2020, Pharmacognosy Magazine CrossRef
8. Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma
   Yinghong Zhou et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
9. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1
   Jackie L. Ha et al, 2024, Medical Oncology CrossRef
10. Self-Renewal Inhibition in Breast Cancer Stem Cells: Moonlight Role of PEDF in Breast Cancer
    Carmen Gil-Gas et al, 2023, Cancers CrossRef